The absence of selling and strong passive buying suggests underlying demand strength. Traders should monitor for follow-on retail or active manager participation, upcoming clinical trial data, or potential inclusion in broader biotech ETFs driving passive inflows.
Executive Summary
Three major passive institutional investors — Morgan Stanley, Wells Fargo, and UBS — significantly increased their positions in Janux Therapeutics (JANX) during Q4 2024, collectively adding $15.2M in new exposure, with UBS doubling its stake. This coordinated accumulation suggests growing institutional confidence in the company’s valuation or pipeline prospects despite no active selling pressure.
Key Financial Metrics
Institutional Positions
Net institutional flow: $15.2M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | ADD | +55.1% | $11.7M | $5.3M |
| Wells Fargo | ADD | +52.9% | $709.0K | $316.0K |
| UBS | DOUBLED | +315.3% | $12.1M | $9.6M |
Key Facts
- Morgan Stanley increased its stake by 55.1%, adding 77.4K shares (value up $5.3M to $11.7M)
- Wells Fargo added 4.6K shares (+52.9%), increasing position value by $316K to $709K
- UBS more than tripled its holdings (+315.3%), adding 170.9K shares and increasing value by $9.6M to $12.1M
- No institutional selling observed in this quarter — net buying of $15.2M across 3 passive mega-funds
Financial Impact
3 institutions accumulated $15.2M in new positions with no offsetting sales, representing a 62% net increase in tracked institutional holdings.
Risk Factors
- All buyers are passive managers, suggesting the move may reflect index rebalancing or ETF flows rather than fundamental conviction
- Low float and small market cap ($819M) increase volatility risk if sentiment shifts
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-JANX-2024-Q4 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 23, 2026 17w ago | 8-K | $14.64 $16.86 | ▲ +15.16% | ▲ +12.33% | — |
Jun 11, 2026 19w ago | Institutional Cluster | $13.66 $20.24 | ▲ +48.17% | ▲ +43.77% | — |
May 7, 2026 24w ago | 8-K | $14.18 $15.96 | ▲ +12.59% | ▲ +7.75% | — |
Feb 28, 2026 34w ago | Institutional Cluster | $13.42 $14.40 | ▲ +7.30% | ▼ −2.02% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers